1.Khalil EAG, Kamil AA, Mukhtar MM, Musa AM, Ibrahim ME, Modabber F, Sacks D, Smith PG, Zicker F and EL-Hassan AM. Intradermal injection of Alum-adsorbed ALM vaccine Plus BCG promotes induction of Th1 cytokines in healthy volunteers. Oral presentation; Oxford 2000, New Challenges in Tropical Medicine and Parasitology

2.Musa AM, Khalil EAG, Ismail A, Fesharki H, Khamesipour A, Modabber F, Elhassan IM and El-Hassan AM. Immunochemotherapy of patients with persistent post kala-azar dermal leishmaniasis (PKDL): a pilot study of safety and possible efficacy. Oral presentation and abstract. Conference on endemic and infectious diseases in Sudan, Ministry of Science and Technology, National Centre for Research, Tropical Medicine Research Institute, Institute of Endemic Diseases, WHO/TDR and Federal Ministry of Health, Sudan. Sharja Hall 5-8 May 2003.
3. Elamin WM, Guerbouj S, Guizani I, Bakhiet SM, El-Hassan SM, El_Hassan AM, Musa AM, Kheir MM and Mukhtar MM. Leishmania archibaldi is the major cause of leishmaniasis in the Sudan. Oral presentation and abstract. Conference on endemic and infectious diseases in Sudan, Ministry of Science and Technology, National Centre for Research,Tropical Medicine Research Institute, Institute of Endemic Diseases, WHO/TDR and Federal Ministry of Health, Sudan. Sharja Hall 5-8 May 2003.
4. Yousif NM, Jensen AT, Musa AM, El-Hassan AM, Khalil EAG and Elhassan IM. Anti-glucose regulated protein 78 (GRP78) antibody responses in Alum/ALM + BCG vaccinees, visceral leishmaniasis and post kala-azar dermal leishmaniasis patients. Oral presentation and abstract. Conference on endemic and infectious diseases in Sudan, Ministry of Science and Technology, National Centre for Research, Tropical Medicine Research Institute, Institute of Endemic Diseases, WHO/TDR and Federal Ministry of Health, Sudan. Sharja Hall 5-8 May 2003.
5. Ayed NB, Musa AM and Khalil EAG. Surrogate markers of immunity to human visceral leishmaniasis. Oral presentation and abstract. Conference on endemic and infectious diseases in Sudan, Ministry of Science and Technology, National Centre for Research, Tropical Medicine Research Institute, Institute of Endemic Diseases, WHO/TDR and Federal Ministry of Health, Sudan. Sharja Hall 5-8 May 2003.
6. Elyamani LE, Khalil EAG, Ibrahim ME, Musa AM and Elhassan IM. Malaria transmission in two villages characterized by seasonal but stable malaria transmission in eastern Sudan. Oral presentation and abstract. Conference on endemic and infectious diseases in Sudan, Ministry of Science and Technology, National Centre for Research, Tropical Medicine Research Institute, Institute of Endemic Diseases, WHO/TDR and Federal Ministry of Health, Sudan. Sharja Hall 5-8 May 2003.
7. Musa AM. Oral presentation. The challenges of managing kala-azar patients in Sudan. DNDi symposium, the 25th African Scientist congress, Nairobi Kenya, 4-8.10.2005.
8. Manal Fadl, E Nancy Miller, M Fakiola, Hiba SM, sara E, A Elzein, EAG Khalil, A M El-Hassan, A M Musa, M E Ibrahim, J M Blackwell. Genome Wide search for visceral leishmaniasis susceptibility genes in Sudanese Population. AMST 3 African Scientist congress, Nairobi, Kenya, 4-8.10.2005.
rd Annual scientific conference, Khartoum, 26th Nov – 3rd
9. Khalil EAG, El-Hassan AM, Musa AM, Zijlstra EE, Ibrahim ME, Mukhtar MM, Modabber F, Zicker F, Keiney MP and Smith PG. Vaccines for visceral leishmaniasis: Sudanese experience. Oral presentation and Abstract: Journal of Clinical Laboratory, XI Congress of the Arab Federation of Clinical Biology, 29th  April to 1 May 2006..
10.Khalil EAG, El-Hassan AM, Musa AM, Zijlstra EE, Ibrahim ME, Mukhtar MM, Modabber F, Zicker F, Keiney MP and Smith PG. Vaccines for visceral leishmaniasis: Sudanese experience. Oral presentation and Abstract: Sudanese Society of Clinical biology, the first Scientific Conference Khartoum, Sudan, Friendship Hall 24 April to 1 May 2006.
th – 27th
11.Khalil EAG, El-Hassan AM, Musa AM, Zijlstra EE, Ibrahim ME, Mukhtar MM, Modabber F, Zicker F, Keiney MP and Smith PG. Vaccines for visceral leishmaniasis: Sudanese experience. Oral presentation and Abstract: Sudanese Society of Clinical biology, the first Scientific Conference Khartoum, Sudan, Friendship Hall 24 November 2006.
th – 27th
12.Musa AM, Khalil EAG, Mahgoub FA, Hamad S, Modabber F, Elkadaru AMY, Aboud MH, Karbwang J, Noazin S and El- Hassan AM. Immunochemotherapy of persistent post kala-azar dermal leishmaniasis: a novel approach of treatment. Oral presentation and Abstract: Sudanese Society of Clinical biology, the first Scientific Conference Khartoum, Sudan, Friendship Hall 24 November 2006.
th – 27th
13. Ismail WMA, Khalil EAG, Bygbjerg IC, Osman, FM, Musa AM and El-Hassan. Coverage & efficacy of BCG vaccination in displaced populations: a measure of effectiveness of expanded program of immunization. Poster and Abstract. Sudanese Society of Clinical biology, the first Scientific Conference Khartoum, November 2006.
18
Sudan, Friendship Hall 24th – 27th
14. Bernawi AAA, Khalil EAG, Morsi AN, Abdelgalil K, Yassin HM and Musa AM. Sero-prevalence and exposure rates of human Echinoccus granulosus infection in Southern Libya. Poster and Abstract. Sudanese Society of Clinical biology, the first Scientific Conference Khartoum, Sudan, Friendship Hall 24 November 2006.
th – 27th
15.Elagib AH, Ahmed AE, Hussein A, Musa AM, Khalil EAG and El-Hassan. Possible predisposing factors for thrombotic cerebrovascular accidents (CVAs) in Sudanese patients. Poster and Abstract. Sudanese Society of Clinical biology, the first Scientific Conference Khartoum, Sudan, Friendship Hall 24th – 27thNovember 2006.
16.Elnour AA, Khalil EAG, Hamad S and Musa AM. Tuberculous Lymphadenitis: Skin delayed type hypersensitivity reaction and cytokines profile as markers of disease and healing. Poster and Abstract. Sudanese Society of Clinical biology, the first Scientific Conference Khartoum, Sudan, Friendship Hall 24 November 2006.
th – 27th
17. El-Hassan OM, Khalil EAG and Musa AM. Trachoma in a cluster of villages of internally displaced population (IDP) in eastern Sudan: Comparison between clinical & serological diagnoses. Poster and Abstract. Sudanese Society of Clinical biology, the first Scientific Conference Khartoum, Sudan, Friendship Hall 24November 2006.
th – 27th
18.Khidir SAE, Khalil EAG, Musa AM and El-hassan AM. Th1/Th2 to Th1 immune response switch: the case of post kala-azar dermal leishmaniasis. Poster and Abstract. Sudanese Society of Clinical biology, the first Scientific Conference Khartoum, Sudan, Friendship Hall 24 November 2006.
th – 27th
19.Hamad S, Khalil EAG, Musa AM, Ibrahim ME and El-Hassan AM. In vitro induction of resistance to sodium stibogluconate (SSG) in Leishmania donovani donovani isolates from Sudan. Poster and Abstract. Sudanese Society of Clinical biology, the first Scientific Conference Khartoum, Sudan, Friendship Hall 24 November 2006.
th – 27th
20. Salih MA, Ibrahim ME, Blackwell JM, Miller EN, Khalil EAG, El-Hassan AM, Musa AM and Mohammed HS. IFNG and IFNGR1 gene polymorphisms and November 2006.
19
susceptibility to post kala-azar dermal leishmaniasis in Sudan. Poster and Abstract. Sudanese Society of Clinical biology, the first Scientific Conference Khartoum, Sudan, Friendship Hall 24th – 27th
21. Musa AM, oral presentation about the preliminary results and further dose ranging of paromomycin for visceral leishmaniasis- Kassab, Sudan, DNDi symposium UK; A step together in the Right direction: LEAP investigates paromomycin to treat visceral leishmaniasis in Africa, Queen Elizabeth II Conference Centre, London, UK, 13.9.2007. November 2006.